<DOC>
	<DOCNO>NCT01692795</DOCNO>
	<brief_summary>Large randomise trial show cardiovascular medication prescribe patient high cardiovascular risk effective reduce incidence cardiovascular event . Their use recommend United Kingdom international guideline ( e.g . National Institute Clinical Excellence ) . However , medication prevent cardiovascular event patient body research investigate effect cardiovascular medication outcomes myocardial infarction ( MI ) , include clinical presentation , infarct size post-MI mortality . However , independent effect cardiovascular drug post-MI cause mortality unclear , limitation many publish study term cardiovascular drug exposure data . This project utilize prospectively collect data cardiovascular drug use , link MI data hospital mortality record .</brief_summary>
	<brief_title>Cardiovascular Medication Use Before First Myocardial Infarction</brief_title>
	<detailed_description />
	<mesh_term>Infarction</mesh_term>
	<mesh_term>Myocardial Infarction</mesh_term>
	<criteria>Patients GPRD practice deem `` standard '' GPRD criterion include practice agree link Myocardial Ischaemic National Audit Project ( MINAP ) , Hospital Episode Statistics ( HES ) Office National Statistics ( ONS ) datasets . Patients must least one year GPRD `` standard '' registration date first myocardial infarction . Age 18 . First myocardial infarction occur 1st January 2003 31st December 2008 , record HES data MINAP . Patients exclude fulfil one inclusion criterion .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>October 2015</verification_date>
	<keyword>Myocardial infarction</keyword>
	<keyword>Antiplatelets</keyword>
	<keyword>Lipid lower agent</keyword>
	<keyword>ACE inhibitor</keyword>
	<keyword>Angiotensin Receptor Blockers</keyword>
	<keyword>Beta blocker</keyword>
	<keyword>Blood pressure lower drug</keyword>
</DOC>